Hepatitis B and C Diagnostics Market Share, Size, Trends and Forecasts 2016-2020
- Submitted by: Marketreport
- Views: 75
- Category: Other
- Date Submitted: 09/16/2016 12:58 AM
- Pages: 4
- Report this Essay
Technavio Announces the Publication of its Research Report Global Hepatitis B and C Diagnostics Market 2016-2020
Technavio recognizes the following companies as the key players in the global hepatitis B and C diagnostics market: Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare, and QIAGEN.
Other Prominent Vendors in the market are: Affymetrix, Allele Biotechnology, Axis-Shield, Becton Dickinson, bioMérieux, Cepheid¸ Chembio Diagnostics, DiaMetra, DiaSorin, Enzo Life Sciences, Hologic, ImmunoDX, MedMira, OraSure Technologies, Quest Diagnostics, Quidel, Randox Laboratories, Vela Diagnostics, Vital Diagnostics, and ZEUS Scientific.
Browse full report with TOC@ https://marketreportscenter.com/reports/383369/global-hepatitis-b-and-c-diagnostics-market-2016-2020
Commenting on the report, an analyst from Technavios team said: One of the key trends for market growth will be high demand for biomarker-based tests. Sophisticated R&D for proteomics, nucleic acid expression, and genome sequencing has led to the emergence of molecular biomarkers. Biomarkers are proteins, genes, hormones, and other molecular entities that detect the absence or presence of a disease. Technological advancements are driving manufacturers to develop assays that identify biomarkers in high-growth clinical areas such as infectious diseases, including hepatitis and retroviruses. Biomarker-based tests will likely replace conventional drug therapeutics and account for increased revenue and sales from personalized test devices. To better reach the market, companies are developing cost-effective biomarker-based tests. Increased approvals for devices and rise in product launches are expected to propel market growth during the forecast period.
According to the report, increase in demand for automation and system integration will be a key driver for market growth. An increasing number of consumers are opting for fully automated and semi-automated systems over conventional (manual)...
Technavio recognizes the following companies as the key players in the global hepatitis B and C diagnostics market: Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare, and QIAGEN.
Other Prominent Vendors in the market are: Affymetrix, Allele Biotechnology, Axis-Shield, Becton Dickinson, bioMérieux, Cepheid¸ Chembio Diagnostics, DiaMetra, DiaSorin, Enzo Life Sciences, Hologic, ImmunoDX, MedMira, OraSure Technologies, Quest Diagnostics, Quidel, Randox Laboratories, Vela Diagnostics, Vital Diagnostics, and ZEUS Scientific.
Browse full report with TOC@ https://marketreportscenter.com/reports/383369/global-hepatitis-b-and-c-diagnostics-market-2016-2020
Commenting on the report, an analyst from Technavios team said: One of the key trends for market growth will be high demand for biomarker-based tests. Sophisticated R&D for proteomics, nucleic acid expression, and genome sequencing has led to the emergence of molecular biomarkers. Biomarkers are proteins, genes, hormones, and other molecular entities that detect the absence or presence of a disease. Technological advancements are driving manufacturers to develop assays that identify biomarkers in high-growth clinical areas such as infectious diseases, including hepatitis and retroviruses. Biomarker-based tests will likely replace conventional drug therapeutics and account for increased revenue and sales from personalized test devices. To better reach the market, companies are developing cost-effective biomarker-based tests. Increased approvals for devices and rise in product launches are expected to propel market growth during the forecast period.
According to the report, increase in demand for automation and system integration will be a key driver for market growth. An increasing number of consumers are opting for fully automated and semi-automated systems over conventional (manual)...